Nanomedicine & Nanopharmaceuticals

The first nanomedicines approved for use were developed from research dating back to the 1970s.Nanopharmaceuticals such as liposomes, quantum dots, dendrimers, carbon nanotubes and polymeric nanoparticles have brought considerable changes in drug delivery and the medical system. Improved therapeutic activity and reduced toxicity in the nonclinical model systems has been showed these liposomal formulations of existing drugs showed. There is a great benefit for the patients in comparison with the conventional drugs in Nanopharmaceuticals. This fact, combined with the technical challenges in commercial-scale production of nanoparticles, led to only limited investment in nanomedicines by the major pharmaceutical companies enhanced oral bioavailability, improved dose proportionality, enhanced solubility and dissolution rate, suitability for administration and reduced food effects are several advantages of these drugs.

    Related Conference of Nanomedicine & Nanopharmaceuticals

    October 21-22, 2024

    41st Global Summit on Nanoscience and Technology

    London, UK
    October 24-25, 2024

    11th Global Conference on Smart Materials and Nanotechnology

    Zurich, Switzerland
    October 24-25, 2024

    40th International Conference on Advanced Nanotechnology

    Zurich, Switzerland
    December 02-03, 2024

    10th Annual Meet on Nanoscience and Nanotechnology

    Prague, Czech Republic
    March 17-18, 2025

    8th International Conference on Nanomedicine and Nanotechnology

    Singapore City, Singapore
    April 14-15, 2025

    37th Nano Congress for Future Advancements

    Aix-en-Provence, France

    Nanomedicine & Nanopharmaceuticals Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in